PFE Jul 2024 23.000 call
- Zacks
Pfizer (PFE) Stock Sinks As Market Gains: Here's Why
Pfizer (PFE) closed at $27.99 in the latest trading session, marking a -1.3% move from the prior day.
- Zacks
Novavax (NVAX) Seeks Nod for Updated COVID-19 Jab in Europe
Novavax (NVAX) seeks marketing authorization in the European Union for an updated version of its COVID-19 vaccine, which has been formulated to target the JN.1 variant.
- Bloomberg
Alnylam Soars After Drug Meets Goal in Heart Disease Trial
(Bloomberg) -- Alnylam Pharmaceuticals Inc. shares soared after its drug succeeded in treating a progressive and deadly form of heart disease, potentially opening up a new avenue for the company’s top-selling product. Most Read from BloombergJain Global Raises $5.3 Billion, Secures Cash From Abu DhabiHow Long Can High Rates Last? Bond Markets Say Maybe ForeverBuzzFeed Struggles to Sell Owner of Hit YouTube Show ‘Hot Ones’Tech Hits Stocks as Nvidia Extends Selloff to 13%: Markets WrapNvidia Sales
